Key result
In men with type 2 diabetes, the presence of erectile dysfunction was not significantly associated with a higher 10-year atherosclerotic cardiovascular disease risk score compared to those without erectile dysfunction (9.11% vs 8.82%, p=0.636).
Why the study?
Erectile dysfunction is a common, distressing complication of diabetes that may serve as an independent marker of CAD.
Does erectile dysfunction correlate with cardiovascular risk (ASCVD score) and glycemic control in men with type 2 diabetes mellitus?
Population
180 diabetic patients
Comparison
Patients with ED vs patients without ED
Design
Cross-sectional study
Authors
Loading...
Erectile dysfunction should not yet inform ASCVD risk assessment in type 2 diabetes men; leaves open longitudinal associations.
Cross-Sectional (n=180)
No
Does erectile dysfunction correlate with cardiovascular risk (ASCVD score) and glycemic control in men with type 2 diabetes mellitus?
Absolute Event Rate: 9.11% vs 8.82%
p-value: p=0.636
In men with type 2 diabetes, erectile dysfunction is highly prevalent and associated with poor glycemic control, though it did not significantly correlate with a higher 10-year ASCVD risk score in this small cohort.
Maury et al. (2022) conducted a cross-sectional in Type 2 diabetes mellitus (n=180). Erectile dysfunction vs. No erectile dysfunction was evaluated on ASCVD risk score (%) (95% CI -1.266 to 2.066, p=0.636). In men with type 2 diabetes, the presence of erectile dysfunction was not significantly associated with a higher 10-year atherosclerotic cardiovascular disease risk score compared to those without erectile dysfunction (9.11% vs 8.82%, p=0.636).